These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25633247)

  • 1. Synthesis and biological evaluation of [¹¹C]AZ12504948; a novel tracer for imaging of glucokinase in pancreas and liver.
    Jahan M; Johnström P; Nag S; Takano A; Korsgren O; Johansson L; Halldin C; Eriksson O
    Nucl Med Biol; 2015 Apr; 42(4):387-94. PubMed ID: 25633247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of cycloalkyl-fused N-thiazol-2-yl-benzamides as tissue non-specific glucokinase activators: Design, synthesis, and biological evaluation.
    Wang Z; Shi X; Zhang H; Yu L; Cheng Y; Zhang H; Zhang H; Zhou J; Chen J; Shen X; Duan W
    Eur J Med Chem; 2017 Oct; 139():128-152. PubMed ID: 28800453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A PET Tracer for Brain α2C Adrenoceptors, (11)C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice.
    Arponen E; Helin S; Marjamäki P; Grönroos T; Holm P; Löyttyniemi E; Någren K; Scheinin M; Haaparanta-Solin M; Sallinen J; Solin O
    J Nucl Med; 2014 Jul; 55(7):1171-7. PubMed ID: 24799619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and preclinical evaluation of the CRTH2 antagonist [
    Eriksson J; Roy T; Sawadjoon S; Bachmann K; Sköld C; Larhed M; Weis J; Selvaraju RK; Korsgren O; Eriksson O; Odell LR
    Nucl Med Biol; 2019 Apr; 71():1-10. PubMed ID: 31082767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure based design, synthesis and biological evaluation of amino phosphonate derivatives as human glucokinase activators.
    Yellapu NK; Kilaru RB; Chamarthi N; Pvgk S; Matcha B
    Comput Biol Chem; 2017 Jun; 68():118-130. PubMed ID: 28327441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [N-methyl-11C]cholylsarcosine, a novel bile acid tracer for PET/CT of hepatic excretory function: radiosynthesis and proof-of-concept studies in pigs.
    Frisch K; Jakobsen S; Sørensen M; Munk OL; Alstrup AK; Ott P; Hofmann AF; Keiding S
    J Nucl Med; 2012 May; 53(5):772-8. PubMed ID: 22454486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular targeting of the GK-GKRP pathway in diabetes.
    Hale C; Lloyd DJ; Pellacani A; Véniant MM
    Expert Opin Ther Targets; 2015 Jan; 19(1):129-39. PubMed ID: 25324018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of novel thiazol-2-yl benzamide derivatives as glucokinase activators.
    Charaya N; Pandita D; Grewal AS; Lather V
    Comput Biol Chem; 2018 Apr; 73():221-229. PubMed ID: 29518630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of 3,5-disubstituted benzamides as glucokinase activators with potent in vivo efficacy.
    Iino T; Hashimoto N; Sasaki K; Ohyama S; Yoshimoto R; Hosaka H; Hasegawa T; Chiba M; Nagata Y; Eiki J; Nishimura T
    Bioorg Med Chem; 2009 Jun; 17(11):3800-9. PubMed ID: 19427223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling and identification of novel glucokinase activators through stepwise virtual screening.
    Behera PM; Behera DK; Satpati S; Agnihotri G; Nayak S; Padhi P; Dixit A
    J Mol Graph Model; 2015 Apr; 57():122-30. PubMed ID: 25723349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of ([(11)C]carbonyl)raclopride and a comparison with ([(11)C]methyl)raclopride in a monkey PET study.
    Rahman O; Takano A; Amini N; Dahl K; Kanegawa N; Långström B; Farde L; Halldin C
    Nucl Med Biol; 2015 Nov; 42(11):893-8. PubMed ID: 26272268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 3-(4-methanesulfonylphenoxy)-N-[1-(2-methoxy-ethoxymethyl)-1H-pyrazol-3-yl]-5-(3-methylpyridin-2-yl)-benzamide as a novel glucokinase activator (GKA) for the treatment of type 2 diabetes mellitus.
    Park K; Lee BM; Hyun KH; Lee DH; Choi HH; Kim H; Chong W; Kim KB; Nam SY
    Bioorg Med Chem; 2014 Apr; 22(7):2280-93. PubMed ID: 24588963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Salicylic acid derivatives as simplified and novel GK small molecule activators].
    Huo LC; Zhang YL; Lei L; Liu SN; Shen ZF; Wang YL; Song HR; Feng ZQ
    Yao Xue Xue Bao; 2013 Apr; 48(4):514-20. PubMed ID: 23833938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucokinase in chicken (Gallus gallus). Partial cDNA cloning, immunodetection and activity determination.
    Berradi H; Taouis M; Cassy S; Rideau N
    Comp Biochem Physiol B Biochem Mol Biol; 2005 Jun; 141(2):129-39. PubMed ID: 15878833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of glucokinase by glucose, small-molecule activator and glucokinase regulatory protein: steady-state kinetic and cell-based analysis.
    Bourbonais FJ; Chen J; Huang C; Zhang Y; Pfefferkorn JA; Landro JA
    Biochem J; 2012 Feb; 441(3):881-7. PubMed ID: 22044397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 2-pyridylureas as glucokinase activators.
    Hinklin RJ; Aicher TD; Anderson DA; Baer BR; Boyd SA; Condroski KR; DeWolf WE; Kraser CF; McVean M; Rhodes SP; Sturgis HL; Voegtli WC; Williams L; Houze JB
    J Med Chem; 2014 Oct; 57(19):8180-6. PubMed ID: 25203462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological evaluation of ¹¹C-labeled piperazine derivative as a PET probe for sigma-2 receptor imaging.
    Selivanova SV; Toscano A; Abate C; Berardi F; Müller A; Krämer SD; Schibli R; Ametamey SM
    Nucl Med Biol; 2015 Apr; 42(4):399-405. PubMed ID: 25637276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of piragliatin--first glucokinase activator studied in type 2 diabetic patients.
    Sarabu R; Bizzarro FT; Corbett WL; Dvorozniak MT; Geng W; Grippo JF; Haynes NE; Hutchings S; Garofalo L; Guertin KR; Hilliard DW; Kabat M; Kester RF; Ka W; Liang Z; Mahaney PE; Marcus L; Matschinsky FM; Moore D; Racha J; Radinov R; Ren Y; Qi L; Pignatello M; Spence CL; Steele T; Tengi J; Grimsby J
    J Med Chem; 2012 Aug; 55(16):7021-36. PubMed ID: 22809456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT2A antagonists for molecular imaging.
    Debus F; Herth MM; Piel M; Buchholz HG; Bausbacher N; Kramer V; Lüddens H; Rösch F
    Nucl Med Biol; 2010 May; 37(4):487-95. PubMed ID: 20447561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a new class of glucokinase activators through structure-based design.
    Hinklin RJ; Boyd SA; Chicarelli MJ; Condroski KR; DeWolf WE; Lee PA; Lee W; Singh A; Thomas L; Voegtli WC; Williams L; Aicher TD
    J Med Chem; 2013 Oct; 56(19):7669-78. PubMed ID: 24015910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.